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Abstract
Introduction: We describe a case of giant cell arteritis in a woman who was treated with high-
dose systemic corticosteroids and subsequently developed acute pancreatitis.
Case presentation: A 78-year-old Caucasian woman presented with four weeks of progressive
headache and scalp tenderness. One day before ophthalmology assessment, she had experienced
visual obscurations in both eyes. Her visual acuity was 6/9 in both eyes, with a right afferent
pupillary defect and right swollen optic nerve. She was diagnosed as having temporal arteritis and
was urgently treated with high-dose pulsed intravenous and oral corticosteroids. Her previous
diet-controlled diabetes needed insulin and oral hyperglycaemic therapy to control erratic blood
sugars. On day 8 of treatment with steroids, she became unwell with epigastric pain and vomiting.
She was diagnosed with acute pancreatitis and was treated conservatively.
Conclusion: Acute pancreatitis, a potentially life-threatening condition, is a rare but important
side effect of systemic corticosteroids.
Introduction
Giant cell arteritis (GCA) remains an enigmatic but seri-
ous systemic disorder that can lead to total irreversible
blindness if not diagnosed and treated swiftly. The recom-
mended treatment is systemic steroids and the initial dose
is large [1]. Unlike rheumatologists, ophthalmologists
tend to use larger doses, 1.2 to 2 mg/kg per day of pred-
nisolone [1] and this probably reflects the different dis-
ease characteristics seen by the two specialities.
The common systemic side effects of prednisolone, such
as gastrointestinal disturbances, dyspepsia, weight gain,
neuropsychiatric changes and osteoporosis, are well
known. However, acute pancreatitis is less well known.
Only two cases of acute pancreatitis exist in the ophthal-
mic literature following high-dose methylprednisolone
treatment for acute optic neuritis [2,3]. The authors
believe that our case highlights the first reported compli-
cation following corticosteroid treatment for vision
threatening GCA.
Case presentation
A 78-year-old Caucasian woman, previously fit and with
diet-controlled diabetes, complained of weight loss, pro-
gressive malaise, jaw claudication and scalp tenderness for
1 month. One day before assessment, she had had tran-
sient complete loss of vision in her right eye and partial
loss of vision in her left eye. Her visual acuity was 6/9 in
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both eyes; colour vision, as tested with Ishihara pseudo-
chromatic plates, was markedly reduced in the right eye
(06/17) and normal in the left (17/17). A right afferent
pupillary defect was present and dilated fundal examina-
tion revealed a right swollen optic nerve. On examination,
she had a right tender, nodular, non-pulsatile temporal
artery. The erythrocyte sedimentation rate (ESR) was 74
mm/hour (normal for women ≥50 years old: ≤30 mm/
hour) and C-reactive protein (C-RP) was >52 mg/litre
(normal C-RP <5 mg/litre).
She had emergency treatment with high-dose pulsed
intravenous methylprednisolone 250 mg BD and oral
prednisolone 80 mg OD to prevent visual loss. She was
also started on oral alendronic acid 70 mg once weekly
and oral ranitidine 150 mg BD. Her symptoms resolved
and her inflammatory markers improved over the next 3
days (ESR 60 mm/hour, C-RP 42 mg/litre), intravenous
steroids were stopped and she continued on 80 mg of oral
prednisolone OD. However, her glycaemic control wors-
ened (blood glucose 22.8 mmol/litre) and she was man-
aged initially with oral hypoglycaemics (metformin 850
mg OD from day 2); glibenclamide 160 mg BD was added
by day 4; and subcutaneous insulin (24 units OM and 6
units nocte) at day 6 finally stabilised the hyperglycaemia
(blood glucose 11.6 mmol/litre). At day 8 she became
unwell with epigastric pain and vomiting. An abdominal
X-ray excluded bowel perforation and clinical chemistry
revealed normal liver function tests and an abnormally
high serum amylase of 459 U/litre (normal range 0 to 99
U/litre). She was managed conservatively with intrave-
nous fluids and analgesia. Her serum amylase normalised
over 48 hours and her symptoms resolved and she was
discharged with resolving right disc oedema (ESR 14 mm/
hour).
She has remained under care with regular blood monitor-
ing and after 8 months is currently maintained on 12.5
mg of prednisolone OD. No symptoms of pancreatitis or
GCA have returned. On examination, she has temporal
pallor of the right optic nerve (Figure 1) and a normal left
optic nerve (Figure 2).
Discussion
Bowel ischaemia or infarction secondary to involvement
of the mesenteric arteries has been reported as a rare
extracranial feature of GCA [4]. The blood supply to the
pancreas is from the splenic, gastroduodenal and superior
mesenteric arteries [5], however, it is unlikely that GCA is
the cause in this patient. The pancreatitis started after 8
days of high-dose steroid treatment, there was no evi-
dence of bowel perforation on abdominal X-ray and the
pancreatitis settled with conservative treatment and has
not reoccurred after 8 months of follow-up. Another pos-
sibility is that the pancreatitis could be secondary to dis-
seminated visceral giant cell arteritis. However, this is
unlikely as Lie [6], who coined this entity, reported on
four male cases none of whom had symptomatic tempo-
ral arteritis and all were diagnosed posthumously.
Acid-suppressing drugs, such as H2-receptor antagonists
and proton pump inhibitors have also been implicated in
causing drug-induced acute pancreatitis. A large, UK-
based cohort study found no increased risk of acute pan-
creatitis following acid-suppressing drug administration
[7].
Most cases of acute pancreatitis are mild and self-limiting,
however, severe attacks can be fatal. Diagnosis is a combi-
nation of serum amylase levels three times the normal
range (>330 U/litre) and typical clinical features including
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epigastric pain radiating into the back, nausea and vomit-
ing [8].
Only 1% of acute pancreatitis cases are secondary to sys-
temic steroids, and these cases carry a relatively higher
mortality rate (66.7%; n = 4/6) [6] compared to more
common aetiological factors such as gallstones or chronic
alcoholism [8,9]. The mechanism of corticosteroid-
induced pancreatitis is complex and currently unknown.
Conclusion
It is highly probable that this case of acute pancreatitis was
secondary to high-dose systemic steroids and we urge all
physicians to be cognisant of this potentially life-threaten-
ing side effect.
Abbreviations
BD: twice a day; C-RP: C-reactive protein; ESR: erythrocyte
sedimentation rate; GCA: giant cell arteritis; nocte: at
night; OD: once daily; OM: once in the morning
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
DS drafted the manuscript. SPM and SE critically reviewed
the manuscript. TW supervised the patient management.
All authors read and approved the final manuscript.
References
1. Ghanchi FD, Dutton GN: Current concepts in giant cell (tem-
poral) arteritis.  Surv Ophthalmol 1997, 42:99-123.
2. Chrousos GA, Kattah JC, Beck RW, Cleary PA: Side effects of glu-
cocorticoid treatment. Experience of the Optic Neuritis
Treatment Trial.  JAMA 1993, 269:2110-2112.
3. Julve Pardo R, Garcia-Escrig M, Catala Barcelo J, del Val JH, Fernandez
Ponsati J: Acute pancreatitis as an effect of IV methylpred-
nisolone in the treatment of optical neuritis.  Neurologia 1998,
13:372-373.
4. Trimble MA, Weisz MA: Infarction of the sigmoid colon second-
ary to giant cell arteritis.  Rheumatology 2002, 41:108-110.
5. Bertelli E, Di Gregorio F, Mosca S, Batianini A: The arterial blood
supply of the pancreas: a review. V. The dorsal pancreatic
artery. An anatomic review and a radiologic study.  Surg Radiol
Anat 1998, 20:445-452.
6. Lie JT: Disseminated visceral giant cell arteritis: histopatho-
logic description and differentiation from other granuloma-
tous vasculitides.  Am J Clin Pathol 1978, 69:299-305.
7. Eland IA, Huerta Alvarez C, Stricker BHCH, García Rodríguez LA:
The risk of acute pancreatitis associated with acid-suppress-
ing drugs.  Br J Clin Pharmacol 2000, 49:473-478.
8. Beckingham IJ, Bornman PC: Acute pancreatitis.  BMJ 2001,
322:595-598.
9. Trapnell JE, Duncan EHL: Patterns of incidence in acute pancre-
atitis.  BMJ 1975, 2:179-183.